Sky Labs Validates Ring-Type Blood Pressure Monitoring at ESC Congress

Researchers presented new evidence highlighting the device's ability to maintain high data accuracy in challenging clinical scenarios. Professor Ki-Hong Lee of Chonnam National University Hospital reported an 80% analyzable data rate during 24-hour monitoring of atrial fibrillation patients, facilitating the observation of nocturnal blood pressure dipping. Simultaneously, Professor In-Cheol Kim of Keimyung University Dongsan Hospital demonstrated that the device meets strict European Society of Hypertension error margin criteria when compared against conventional ambulatory monitors in severe heart failure cases.

The device, which utilizes PPG sensors and AI deep learning, has already secured a significant footprint in South Korea, with over 300,000 cumulative prescriptions across 2,000 medical institutions. Beyond routine monitoring, clinical applications extended to specialized scenarios, including tracking blood pressure surges in sleep apnea patients and assisting in medication management for those sensitive to cuff-induced stress. As Sky Labs moves toward broader international expansion, the device’s adherence to rigorous validation standards—confirmed by experts like Professor George Stergiou—positions it as a reliable alternative for continuous, personalized cardiovascular care.